$0.39
-0.01 (-3.52%)
Open$0.40
Previous Close$0.41
Day High$0.42
Day Low$0.38
52W High$2.56
52W Low$0.33
Volume—
Avg Volume66.9K
Market Cap4.36M
P/E Ratio—
EPS$-0.29
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+7,027.9% upside
Current
$0.39
$0.39
Target
$27.92
$27.92
$15.39
$27.92 avg
$30.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 54.29M | 66.59M | 3.60M |
| Net Income | -5,774,707 | -6,373,848 | 438.1K |
| Profit Margin | -10.6% | -10.1% | 12.2% |
| EBITDA | -2,932,877 | -3,417,013 | 810.0K |
| Free Cash Flow | — | — | 302.1K |
| Rev Growth | -18.5% | -18.5% | +16.0% |
| Debt/Equity | — | — | 0.63 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |